Commit Lozenge Generic Equivalent Application Filed
This article was originally published in The Tan Sheet
Executive Summary
A recent regulatory submission filed with FDA is seeking 180-day exclusivity for a generic version of nicotine replacement therapy lozenges
You may also be interested in...
Zyrtec-D Paragraph IV Application Submitted To FDA
A generic version of Pfizer's Zyrtec-D 12 Hour is among the Paragraph IV abbreviated new drug applications submitted to FDA early this summer
Zyrtec-D Paragraph IV Application Submitted To FDA
A generic version of Pfizer's Zyrtec-D 12 Hour is among the Paragraph IV abbreviated new drug applications submitted to FDA early this summer
Zyrtec-D Paragraph IV Application Submitted To FDA
A generic version of Pfizer's Zyrtec-D 12 Hour is among the Paragraph IV abbreviated new drug applications submitted to FDA early this summer